Improving health equity in Alzheimer's treatment decisions
Official title: Using the generalized risk-adjusted cost-effectiveness (GRACE) model to advance health equity in use of novel treatments for Alzheimer's Disease and Related Dementias
Funded at Johns Hopkins University · NIH-10975994 · Data updated 2026-11-12
This study is looking at how people with Alzheimer's and their families choose new treatments, by talking to them in groups to understand their thoughts on different medication options, so we can help make better decisions together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $322,286 |
| NIH project number | 1R61AG088961-01 |
| Project ID | NIH-10975994 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Alzheimer's Disease or related dementias, along with their caregivers and family members.
✕Less likely to help
Patients who are not affected by Alzheimer's Disease or related dementias will not benefit from this research.
What this research studies
This research investigates how individuals affected by Alzheimer's Disease and related dementias make decisions about new treatments targeting specific proteins. It involves conducting focus groups to gather insights on the diverse perspectives of patients and their families regarding medication choices. The findings will inform the design of surveys that assess how different treatment attributes are valued, helping to understand the trade-offs patients are willing to make. Ultimately, this approach aims to enhance the decision-making process for patients and caregivers in the context of evolving dementia challenges.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and equitable treatment options for patients with Alzheimer's Disease and related dementias.
How similar studies have gone: Previous research has shown success in using patient-centered approaches to improve treatment decision-making in various health conditions, indicating potential for this novel approach.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Segal, Jodi B. — Johns Hopkins University
- Study coordinator: Segal, Jodi B.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.